|
DE2623228C3
(de)
*
|
1976-05-24 |
1981-09-10 |
Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren |
N-Acyl-substituierte Benzamide, Verfahren zu ihrer Herstellung und Arzneimittel, enthaltend solche Benzamide
|
|
US4456757A
(en)
*
|
1981-03-20 |
1984-06-26 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Isoquinolinesulfonyl derivatives and process for the preparation thereof
|
|
JPS5993054A
(ja)
*
|
1982-11-18 |
1984-05-29 |
Asahi Chem Ind Co Ltd |
イソキノリンスルホン酸アミド誘導体
|
|
DK8386A
(da)
|
1986-01-15 |
1987-07-09 |
Tpo Pharmachim |
Nye n-substituerede 1-benzyl-2-carbamoyltetrahydroisoquinoliner og fremgangsmaade til fremstilling af samme
|
|
US4911928A
(en)
*
|
1987-03-13 |
1990-03-27 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
|
JPH01139528A
(ja)
*
|
1987-11-24 |
1989-06-01 |
Showa Denko Kk |
抗潰瘍剤
|
|
EP0389995B1
(en)
|
1989-03-28 |
1995-05-31 |
Nisshin Flour Milling Co., Ltd. |
Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension
|
|
KR920008026A
(ko)
|
1990-10-24 |
1992-05-27 |
오노 화아마슈티칼 캄파니 리미팃드 |
이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물
|
|
EP0630373A1
(en)
*
|
1992-03-12 |
1994-12-28 |
Smithkline Beecham Plc |
Indole derivatives as 5ht1c antagonists
|
|
DE4332168A1
(de)
*
|
1993-02-22 |
1995-03-23 |
Thomae Gmbh Dr K |
Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5798380A
(en)
*
|
1996-02-21 |
1998-08-25 |
Wisconsin Alumni Research Foundation |
Cytoskeletal active agents for glaucoma therapy
|
|
US6586425B2
(en)
*
|
1996-02-21 |
2003-07-01 |
Wisconsin Alumni Research Foundation |
Cytoskeletal active agents for glaucoma therapy
|
|
US5891646A
(en)
*
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
|
US6720175B1
(en)
*
|
1998-08-18 |
2004-04-13 |
The Johns Hopkins University School Of Medicine |
Nucleic acid molecule encoding homer 1B protein
|
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
|
EP1185509A2
(en)
*
|
1999-05-24 |
2002-03-13 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
EP1192135A2
(en)
|
1999-06-14 |
2002-04-03 |
Eli Lilly And Company |
Serine protease inhibitors
|
|
CA2389681C
(en)
|
1999-11-26 |
2010-11-02 |
Shionogi & Co., Ltd. |
Npy y5 antagonist
|
|
ATE305302T1
(de)
|
1999-12-28 |
2005-10-15 |
Eisai Co Ltd |
Heterozyklische verbindungen mit sulfonamid- gruppen
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
WO2001056607A1
(en)
|
2000-02-03 |
2001-08-09 |
Eisai Co., Ltd. |
Integrin expression inhibitors
|
|
US6410566B1
(en)
*
|
2000-05-16 |
2002-06-25 |
Teijin Limited |
Cyclic amine derivatives and their use as drugs
|
|
US7087632B2
(en)
*
|
2001-03-05 |
2006-08-08 |
Transtech Pharma, Inc. |
Benzimidazole derivatives as therapeutic agents
|
|
US6908741B1
(en)
*
|
2000-05-30 |
2005-06-21 |
Transtech Pharma, Inc. |
Methods to identify compounds that modulate RAGE
|
|
US6323228B1
(en)
|
2000-09-15 |
2001-11-27 |
Abbott Laboratories |
3-substituted indole angiogenesis inhibitors
|
|
EP1335901B1
(en)
|
2000-10-17 |
2010-04-14 |
Merck Serono SA |
Pharmaceutically active sulfanilide derivatives
|
|
US7163800B2
(en)
*
|
2000-11-03 |
2007-01-16 |
Molecular Devices Corporation |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
|
CA2443950C
(en)
|
2001-04-20 |
2011-10-18 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
US6956035B2
(en)
*
|
2001-08-31 |
2005-10-18 |
Inotek Pharmaceuticals Corporation |
Isoquinoline derivatives and methods of use thereof
|
|
DE60320933D1
(de)
*
|
2002-01-10 |
2008-06-26 |
Bayer Healthcare Ag |
Rho-kinase inhibitoren
|
|
US20040180889A1
(en)
|
2002-03-01 |
2004-09-16 |
Pintex Pharmaceuticals, Inc. |
Pin1-modulating compounds and methods of use thereof
|
|
JP4481011B2
(ja)
*
|
2002-03-05 |
2010-06-16 |
トランス テック ファーマ，インコーポレイテッド |
リガンドのｒａｇｅとの相互作用を阻害する単環式および二環式アゾール誘導体
|
|
US7645878B2
(en)
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
|
GB0206876D0
(en)
|
2002-03-22 |
2002-05-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2003097795A2
(en)
*
|
2002-05-13 |
2003-11-27 |
Norak Biosciences, Inc. |
Constitutively translocating cell line
|
|
US7345158B2
(en)
*
|
2002-08-30 |
2008-03-18 |
Anges Mg, Inc. |
Actin related cytoskeletal protein “LACS”
|
|
EP1550660A1
(en)
|
2002-09-12 |
2005-07-06 |
Kirin Beer Kabushiki Kaisha |
Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
|
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
MXPA05013434A
(es)
*
|
2003-06-12 |
2006-03-17 |
Astellas Pharma Inc |
Derivados de benzamida o sal del mismo.
|
|
EP1663204B1
(en)
|
2003-08-29 |
2014-05-07 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
|
EP1689393A4
(en)
*
|
2003-10-06 |
2008-12-17 |
Glaxo Group Ltd |
PREPARATION OF 1,7-DISUBSTITUTED AZABENZIMIDAZOLES AS KINASE INHIBITORS
|
|
DE10348023A1
(de)
|
2003-10-15 |
2005-05-19 |
Imtm Gmbh |
Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
EP2468729B1
(en)
*
|
2003-10-15 |
2013-12-25 |
Ube Industries, Ltd. |
Novel indazole derivative
|
|
JP2007008816A
(ja)
|
2003-10-15 |
2007-01-18 |
Ube Ind Ltd |
新規イソキノリン誘導体
|
|
SE0400284D0
(sv)
*
|
2004-02-10 |
2004-02-10 |
Astrazeneca Ab |
Novel compounds
|
|
JP2005227441A
(ja)
|
2004-02-12 |
2005-08-25 |
Konica Minolta Medical & Graphic Inc |
光熱写真画像形成材料
|
|
US7592357B2
(en)
*
|
2004-02-20 |
2009-09-22 |
Smithkline Beecham Corporation |
Compounds
|
|
US20080096238A1
(en)
*
|
2004-03-30 |
2008-04-24 |
Alcon, Inc. |
High throughput assay for human rho kinase activity with enhanced signal-to-noise ratio
|
|
DE102004017438A1
(de)
*
|
2004-04-08 |
2005-11-03 |
Bayer Healthcare Ag |
Hetaryloxy-substituierte Phenylaminopyrimidine
|
|
US7453002B2
(en)
*
|
2004-06-15 |
2008-11-18 |
Bristol-Myers Squibb Company |
Five-membered heterocycles useful as serine protease inhibitors
|
|
WO2006009889A1
(en)
*
|
2004-06-17 |
2006-01-26 |
Smithkline Beecham Corporation |
Novel inhibitors of rho-kinases
|
|
WO2006041119A1
(ja)
|
2004-10-13 |
2006-04-20 |
Eisai R & D Management Co., Ltd. |
ヒドラジド誘導体
|
|
UY29198A1
(es)
|
2004-11-09 |
2006-05-31 |
Cancer Rec Tech Ltd |
Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones
|
|
GB0425026D0
(en)
*
|
2004-11-12 |
2004-12-15 |
Biofocus Discovery Ltd |
Compounds which bind to the active site of protein kinase enzymes
|
|
JP2008523071A
(ja)
|
2004-12-07 |
2008-07-03 |
ルーカス ファーマシューティカルズ， インコーポレイテッド |
Ｍａｐキナーゼの尿素インヒビター
|
|
US20080207677A1
(en)
|
2004-12-31 |
2008-08-28 |
Gpc Biotech Ag |
Napthyridine Compounds As Rock Inhibitors
|
|
AU2006204724A1
(en)
|
2005-01-14 |
2006-07-20 |
Millennium Pharmaceuticals, Inc. |
Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
|
|
US20090005321A1
(en)
*
|
2005-02-09 |
2009-01-01 |
Microbia, Inc. |
Phenylazetidinone Derivatives
|
|
CN101180273A
(zh)
*
|
2005-05-25 |
2008-05-14 |
惠氏公司 |
合成6-烷基氨基喹啉衍生物的方法
|
|
WO2007008942A2
(en)
|
2005-07-11 |
2007-01-18 |
Aerie Pharmaceuticals, Inc. |
Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
|
|
WO2007008926A1
(en)
*
|
2005-07-11 |
2007-01-18 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
|
EP1951253A2
(en)
*
|
2005-10-26 |
2008-08-06 |
Cotherix, Inc. |
Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
|
|
TW200738682A
(en)
|
2005-12-08 |
2007-10-16 |
Organon Nv |
Isoquinoline derivatives
|
|
EP1962853A1
(en)
|
2005-12-22 |
2008-09-03 |
Alcon Research, Ltd. |
(indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions
|
|
AR057252A1
(es)
|
2005-12-27 |
2007-11-21 |
Alcon Mfg Ltd |
Inhibicion de rho quinasa mediada por arni para el tratamiento de trastornos oculares
|
|
JP5476559B2
(ja)
|
2006-02-10 |
2014-04-23 |
国立大学法人九州大学 |
リン酸化酵素の新規基質ポリペプチド
|
|
WO2007100880A1
(en)
|
2006-02-28 |
2007-09-07 |
Amgen Inc. |
Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
|
|
JP2007246466A
(ja)
|
2006-03-17 |
2007-09-27 |
Osaka Univ |
中枢神経損傷に対する嗅粘膜移植にＲｈｏキナーゼ阻害剤を用いた神経機能再建法
|
|
WO2007142323A1
(ja)
|
2006-06-08 |
2007-12-13 |
Ube Industries, Ltd. |
側鎖にスピロ環構造を有する新規インダゾール誘導体
|
|
US20090318485A1
(en)
|
2006-07-20 |
2009-12-24 |
Kalypsys, Inc. |
Novel inhibitors of rho kinase
|
|
EP2044061A2
(en)
*
|
2006-07-20 |
2009-04-08 |
Mehmet Kahraman |
Benzothiophene inhibitors of rho kinase
|
|
BRPI0714782A2
(pt)
|
2006-07-31 |
2013-07-16 |
Senju Pharma Co |
preparaÇço lÍquida aquosa contendo composto de amida
|
|
WO2008036540A2
(en)
*
|
2006-09-20 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
|
WO2008054599A2
(en)
|
2006-09-27 |
2008-05-08 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
|
US20090036465A1
(en)
|
2006-10-18 |
2009-02-05 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
WO2008049919A2
(en)
|
2006-10-26 |
2008-05-02 |
Devgen N.V. |
Rho kinase inhibitors
|
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
|
WO2008079945A2
(en)
|
2006-12-20 |
2008-07-03 |
University Of South Florida |
Rock inhibitors and uses thereof
|
|
AR064420A1
(es)
*
|
2006-12-21 |
2009-04-01 |
Alcon Mfg Ltd |
Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop).
|
|
KR20090103903A
(ko)
|
2006-12-27 |
2009-10-01 |
사노피-아벤티스 |
사이클로알킬아민 치환된 이소퀴놀론 및 이소퀴놀리논 유도체
|
|
EP2114920A1
(en)
*
|
2006-12-27 |
2009-11-11 |
Sanofi-Aventis |
Substituted isoquinoline and isoquinolinone derivatives
|
|
NZ577980A
(en)
|
2006-12-27 |
2012-01-12 |
Sanofi Aventis |
Cycloalkylamine substituted isoquinolone derivatives
|
|
RU2468011C2
(ru)
|
2006-12-27 |
2012-11-27 |
Санофи-Авентис |
Замещенные циклоалкиламином производные изохинолина и изохинолинона
|
|
RU2455302C2
(ru)
|
2006-12-27 |
2012-07-10 |
Санофи-Авентис |
ЗАМЕЩЕННЫЕ ИЗОХИНОЛИНОВЫЕ И ИЗОХИНОЛИНОНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ
|
|
KR20090092303A
(ko)
|
2006-12-27 |
2009-08-31 |
사노피-아벤티스 |
사이클로알킬아민 치환된 이소퀴놀린 유도체
|
|
WO2008077555A2
(en)
|
2006-12-27 |
2008-07-03 |
Sanofi-Aventis |
Substituted isoquinolines and their use as rho-kinase inhibitors
|
|
US8455513B2
(en)
*
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
|
CA2683647A1
(en)
*
|
2007-04-10 |
2008-10-16 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US8455514B2
(en)
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
|
US8450344B2
(en)
*
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
EP3053913B1
(en)
|
2009-05-01 |
2018-03-07 |
Aerie Pharmaceuticals, Inc. |
Dual mechanism inhibitors for the treatment of disease
|